Literature DB >> 2239664

ACE inhibition improves vagal reactivity in patients with heart failure.

K J Osterziel1, R Dietz, W Schmid, K Mikulaschek, J Manthey, W Kübler.   

Abstract

The deranged autonomic control of heart rate was studied in 34 patients with heart failure (New York Heart Association [NYHA] functional class II to III) by examining the carotid sinus baroreflex. The carotid sinus baroreceptors were stimulated by graded suction. The slope of the regression line between increases in cycle length and the degree of neck suction was taken as an index of baroreflex sensitivity. The reflex response is mediated by a selective increase of vagal efferent activity. Baroreflex sensitivity therefore represents a measure of vagal reactivity. Using multiple regression analysis, baroreflex sensitivity (BS) correlated positively to stroke volume index (SVI) and inversely to plasma renin activity (PRA) and to age: BS = 0.47 SVI - 0.38 PRA - 0.23 age + constant (r = 0.74; p less than 0.0005). In addition to digitalis and diuretics, angiotensin-converting enzyme (ACE) inhibitors (captopril or enalapril) were given to 16 patients for a mean of 17 +/- 3 days. The patients with hemodynamic improvement (group A) exhibited improved baroreflex sensitivity (1.4 +/- 0.4 to 3.6 +/- 1.2 msec/mm Hg; p less than 0.01). Baroreflex sensitivity remained unchanged (3.1 +/- 0.8 to 2.4 +/- 1.0 msec/mm Hg; n.s.) in the patients without hemodynamic improvement (group B). The increase in reflex sensitivity did not correlate with hemodynamic alterations. Baroreflex sensitivity during ACE inhibition (BSD) was only related to the baseline baroreflex sensitivity (BSB): BSD = 2.8 BSB - 0.46 (r = 0.84; p less than 0.005). In patients with heart failure, reflex bradycardia decreases with age and with PRA and increases with stroke volume. Chronic therapy with ACE inhibitors enhances vagal reactivity in patients with hemodynamic improvement.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2239664     DOI: 10.1016/0002-8703(90)90125-h

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man.

Authors:  K M Yee; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 2.  The sympathetic nervous system and baroreflexes in hypertension and hypotension.

Authors:  J L Izzo; A A Taylor
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

3.  Predominant beta-adrenoceptor blocking effect of xamoterol averaged over the day in patients with mild to moderate heart failure: insight into the mechanism of its long-term clinical efficacy.

Authors:  H Ozaki; H Sato; M Hori; T Matsuyama; K Imai; H Yokoyama; A Kitabatake; M Inoue; T Kamada
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Low-dose combination therapy with metoprolol and captopril for congestive heart failure in mice.

Authors:  T Kanda; M Inoue; T Suzuki; K Murata
Journal:  Cardiovasc Drugs Ther       Date:  1993-11       Impact factor: 3.727

5.  Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure.

Authors:  K J Osterziel; D Hänlein; R Willenbrock; C Eichhorn; F Luft; R Dietz
Journal:  Br Heart J       Date:  1995-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.